NCT00139243View on ClinicalTrials.gov

Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 1997

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Squamous Cell CarcinomaCarcinoma of Head and/or Neck
Interventions
DRUG

Taxotere

DRUG

Cisplatin

DRUG

5-Fluorouracil

DRUG

Leucovorin

Trial Locations (2)

02115

Dana-Farber Cancer Institute, Boston

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

collaborator

Brigham and Women's Hospital

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Dana-Farber Cancer Institute

OTHER